Reframing the association and significance of co‐morbidities in heart failure. (30th June 2016)

• Record Type: Journal Article
• Authors: Triposkiadis, Filippos; Giamouzis, Gregory; Parissis, John; Starling, Randall C.; Boudoulas, Harisios; Skoularigis, John; Butler, Javed; Filippatos, Gerasimos
• Is Part Of: European journal of heart failure. Volume 18:Number 7(2016)
• Page Start: 744
• Page End: 758
• Publication Date: 2016-06-30
• Subjects: Heart failure -- Hypertension -- Coronary artery disease -- Myocardial infarction -- Atrial fibrillation -- Obstructive pulmonary disease -- Anaemia -- Diabetes -- Kidney disease -- Renal failure -- Sleep‐disordered breathing -- Obesity -- Depression; Heart failure -- Periodicals; Heart Failure -- Periodicals; Insuffisance cardiaque -- Périodiques; Heart failure; Periodicals; 616.129005
• DOI: 10.1002/ejhf.600
• Languages: English
• ISSNs: 1388-9842

Abstract

Abstract : Several co‐existing diseases and/or conditions (co‐morbidities) are present in patients with heart failure (HF), with diverse clinical relevance. Multiple mechanisms may underlie the co‐existence of HF and co‐morbidities, including direct causation, associated risk factors, heterogeneity, and independence. The complex inter‐relationship of co‐morbidities and their impact on the cardiovascular system contribute to the features of HF, both with reduced (HFrEF) and preserved ejection fraction (HFpEF). The purpose of this work is to provide an overview of the contribution of major cardiac and non‐cardiac co‐morbidities to HF development and outcomes, in the context of both HFpEF and HFrEF. Accordingly, epidemiological evidence linking co‐morbidities to HF and the effect of prevalent and incident co‐morbidities on HF outcome will be reviewed.